$97 Million

Quotient Limited

Follow-on Offering

Bookrunner, November 2019

Quotient Limited
Building on 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers a fully automated, consolidated testing platform, allowing for multiple tests across different modalities.